Advanced search
Publication Cover
Expert Review of Vaccines Volume 20, 2021 - Issue 11: Vaccines for Neglected Tropical Diseases
Submit an article Journal homepage
2,451
Views
6
CrossRef citations to date
0
Altmetric
Review

Vaccines against leishmaniasis: using controlled human infection models to accelerate development

Vivak Parkasha York Biomedical Research Institute, Hull York Medical School, University of York, York, UK;b Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield, UKView further author information
,
Paul M. Kayea York Biomedical Research Institute, Hull York Medical School, University of York, York, UKView further author information
,
Alison M Laytona York Biomedical Research Institute, Hull York Medical School, University of York, York, UKView further author information
&
Charles J Laceya York Biomedical Research Institute, Hull York Medical School, University of York, York, UKCorrespondence[email protected]
View further author information
Pages 1407-1418 | Received 01 Aug 2021, Accepted 07 Oct 2021, Published online: 27 Oct 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paul M. Kaye, Sakshi Mohan, Carsten Mantel, Melissa Malhame, Paul Revill, Epke Le Rutte, Vivak Parkash, Alison M. Layton, Charles J.N. Lacey & Stefano Malvolti. (2021) Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert Review of Vaccines 20:11, pages 1419-1430.
Read now

Articles from other publishers (5)

Paul M. Kaye, Vivak Parkash, Alison M. Layton & Charles J. N. Lacey. 2023. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges 263 279 .
Subir Karmakar, Greta Volpedo, Wen-Wei Zhang, Patrick Lypaczewski, Nevien Ismail, Fabiano Oliveira, James Oristian, Claudio Meneses, Sreenivas Gannavaram, Shaden Kamhawi, Shinjiro Hamano, Jesus G. Valenzuela, Greg Matlashewski, Abhay R. Satoskar, Ranadhir Dey & Hira L. Nakhasi. (2022) Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis. npj Vaccines 7:1.
Crossref
Malcolm S. Duthie, Bruna A. S. Machado, Roberto Badaró, Paul M. Kaye & Steven G. Reed. (2022) Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. Pathogens 11:11, pages 1259.
Crossref
Francine Ntoumi & Peter G Kremsner. (2022) Vaccination with fractional doses: promise or illusion?. The Lancet Infectious Diseases 22:9, pages 1258-1259.
Crossref
Amanda S. Machado, Daniela P. Lage, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M.O. Cardoso, Isabela A.G. Pereira, Fernanda F. Ramos, Grasiele S.V. Tavares, Fernanda Ludolf, João A. Oliveira-da-Silva, Raquel S. Bandeira, Aratti C. Simões, Mariana C. Duarte, Jamil S. Oliveira, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins & Eduardo A.F. Coelho. (2022) A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum. Acta Tropica 230, pages 106412.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.